‘Hawaii Senate Committee Approves Bill To Create Therapeutic Psilocybin Working Group’ -Marijuana Moment Report
https://www.marijuanamoment.net/hawaii-senate-committee-approves-bill-to-create-therapeutic-psilocybin-working-group/
EXCLUSIVE: Fox Rothschild Cannabis Attorney Analyzes Psychedelics Regs And Changing Public Perceptions
(Part one of a three-part series)
‘Change To Classification Of Psilocybin And MDMA To Enable Prescribing By Authorized Psychiatrists’; Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change – Australian Government Department Of Health And Aged Care
https://www.tga.gov.au/news/media-releases/change-classification-psilocybin-and-mdma-enable-prescribing-authorised-psychiatrists
From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA
‘Psychedelics Bills Filed In Four More States As 2023 Reform Efforts Heat Up’ -Marijuana Moment Report
https://www.marijuanamoment.net/psychedelics-bills-filed-in-four-more-states-as-2023-reform-efforts-heat-up/
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
GAINERS: LOSERS: Intelgenx Technologies (OTC:IGXT) shares closed down 7.06% at $0.23 Cybin (AMEX:CYBN) shares closed down 4.73% at…
Top 3 Psychedelic Storylines To Watch In 2023
This article by James Hallifax was originally published on Microdose and appears here with permission.
‘Mexican Senator To File Psychedelics Legalization Bill, With U.S. Congressman Backing International Reform Push’ – Marijuana Moment
https://www.marijuanamoment.net/mexican-senator-to-file-psychedelics-legalization-bill-with-u-s-congressman-backing-international-reform-push/
A Mexican senator announced on Wednesday that she will be introducing a bill
Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In Q1 2023
In the race to create faster-acting, safer antidepressants, Vistagen (NASDAQ:VTGN) is starting the year strong as it gets ready to launch a Phase 1 Trial of its novel pherine nasal spray for Major Depressive
Psychedelics Market Could Reach $12B By 2029, Says New Report
A new analysis of the global market for psychedelics performed by Brandessence Market Research shows an expected growth from 2022’s $4.87 billion to an annual valuation of nearly $12 billion before 2030.
Psychedelics Company Numinus Wellness Consolidates Recent Surge Higher: What’s Going On?
Numinus Wellness, Inc (OTC: NUMIF) was consolidating about 2% lower on Wednesday after surging over 30% on Tuesday.